Nurix Therapeutics, Inc. (NRIX) Stock Overview
Explore Nurix Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Nurix Therapeutics, Inc. (NRIX)
Key Financials
Key Financials
Market Cap
2.4B
P/E Ratio
-6.87
EPS (TTM)
$-3.45
ROE
-0.76%
NRIX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Nurix Therapeutics, Inc. (NASDAQ: NRIX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Nurix Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NRIX on the NASDAQ shows an RSI of 62.74, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $20.84 for the NASDAQ listing.
Key metrics behind Nurix Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -6.87 and a market capitalization of 2.4B. Combined with our AI analysis, these give both institutional and retail investors a clear view of NRIX on the NASDAQ.